These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8584651)

  • 41. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
    Samantaray S; Knaryan VH; Butler JT; Ray SK; Banik NL
    J Neurochem; 2008 Mar; 104(5):1309-20. PubMed ID: 18036149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term manganese pretreatment partially protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Rojas P; Ríos C
    Neurochem Res; 1995 Oct; 20(10):1217-23. PubMed ID: 8746808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.
    Gainetdinov RR; Fumagalli F; Jones SR; Caron MG
    J Neurochem; 1997 Sep; 69(3):1322-5. PubMed ID: 9282960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome].
    Iurasov VV; Podgornyĭ GI; Kucherianu VG; Kudrin VS; Nikushkin EV; Zhigal'tsev IV; Sandalov IuG; Kaplun AP; Shvets VI; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1996 Dec; 122(12):614-7. PubMed ID: 9280455
    [No Abstract]   [Full Text] [Related]  

  • 46. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
    Callier S; Morissette M; Grandbois M; Di Paolo T
    Synapse; 2000 Sep; 37(4):245-51. PubMed ID: 10891861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Li S; Pu XP
    Biol Pharm Bull; 2011; 34(8):1291-6. PubMed ID: 21804220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism.
    Arai N; Misugi K; Goshima Y; Misu Y
    Brain Res; 1990 May; 515(1-2):57-63. PubMed ID: 2357577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of acetyl-L-carnitine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
    Harik SI; Hritz MA
    Biochem Pharmacol; 1993 May; 45(10):2170-2. PubMed ID: 8512600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
    J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo.
    Liang LP; Huang J; Fulton R; Day BJ; Patel M
    J Neurosci; 2007 Apr; 27(16):4326-33. PubMed ID: 17442816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective effects of (+/-)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice.
    Ruan H; Yang Y; Zhu X; Wang X; Chen R
    Neurosci Lett; 2009 Jan; 450(2):152-7. PubMed ID: 19070648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
    Heikkila RE; Hess A; Duvoisin RC
    Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
    Shahi GS; Das NP; Moochhala SM
    Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of heat shock proteins in MPTP-induced neurotoxicity.
    Freyaldenhoven TE; Ali SF
    Ann N Y Acad Sci; 1997 Oct; 825():167-78. PubMed ID: 9369985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of the MPTP-treated mouse as an animal model of parkinsonism.
    Heikkila RE; Sonsalla PK
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):436-40. PubMed ID: 3499967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
    Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
    Fillebeen C; Mitchell V; Dexter D; Benaissa M; Beauvillain J; Spik G; Pierce A
    Brain Res Mol Brain Res; 1999 Oct; 72(2):183-94. PubMed ID: 10529477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.